In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors

類似資料

• Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme
  著者:: Bahadur Gurung, Arun, 等
  出版事項: (2020)
• Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach
  著者:: Gurung, Arun Bahadur, 等
  出版事項: (2020)
• The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
  著者:: Gurung, Arun Bahadur, 等
  出版事項: (2021)
• Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
  著者:: Gurung, Arun Bahadur, 等
  出版事項: (2021)
• An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19
  著者:: Gurung, Arun Bahadur, 等
  出版事項: (2021)